AnodyneWiki

Imagabalin

Imagabalin
Imagabalin
Salts
[]
Imagabalin hydrochloride
Imagabalin hydrochloride
Molecular structure drawn from PubChem coordinates
Rotamer
[]
Conformer structure via 3Dmol.js
Enable javascript to view conformer structure via 3Dmol.js
Physical properties
[]
Molecular mass173.25 g/mol [1]
Predicted LogP-0.7 [1]
Structural Identifiers
[]
Molecular formulaC9H19NO2
IUPAC name(3S,5R)-3-amino-5-methyloctanoic acid
SMILESCCC[C@@H](C)C[C@@H](CC(=O)O)N
InChIInChI=1S/C9H19NO2/c1-3-4-7(2)5-8(10)6-9(11)12/h7-8H,3-6,10H2,1-2H3,(H,11,12)/t7-,8+/m1/s1
InChIKeyJXEHXYFSIOYTAH-SFYZADRCSA-N
CAS number610300-07-7
UNIINDG6931B7H
PubChem CID10236037

Imagabalin (also known as Imagabalina, Imagabaline, Pf-00195889, pd0332334, Pd-0332334, (3s,5r)-3-amino-5-methyl-octanoic acid, Pd 0332334, Octanoic acid, 3-amino-5-methyl-, (3S,5R)-, imagabalinum or Pf 00195889).

Chemistry

Salts []

Imagabalin is typically found in the form of its hydrochloride salt.

 []

Imagabalin is a single defined stereoisomer.

Imagabalin matches Lipinski's rule of five.

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 10236037, Imagabalin. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/10236037
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Imagabalin. UNII: NDG6931B7H. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/NDG6931B7H

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 17:44:18
drugspromissing (no DrugsPRO reagent data)2026-11-20 17:44:14
erowidmissing (no Erowid substance of that name)2026-11-20 17:44:14
gsrsok2026-11-20 17:44:15
hmdbmissing (no HMDB id)2026-11-20 17:44:14
keggok2026-11-20 17:44:16
pubchemok2026-11-20 17:44:13
redditmissing (no r/tripreports posts mention it)2026-11-20 17:44:14
sidermissing (not in SIDER)2026-11-20 17:44:14
structureok2026-11-20 17:44:14
wikipediaok2026-11-20 17:44:14